ACE |
|
|
Clinical Trial: Hypertension in Hemodialysis
This study is currently recruiting patients.
Purpose
How we should diagnose high blood pressure in hemodialysis patients and treat it using medications or without medications is the purpose of this study
| Condition | Treatment or Intervention |
|---|---|
| Hypertension hemodialysis Left Ventricular Hypertrophy | Procedure: Ultrafiltration Drug: ACE inhibitors or beta blockers |
MedlinePlus related topics: Heart Diseases; Heart Diseases--Prevention; High Blood Pressure
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Expected Total Enrollment: 150
Study start: August 2003
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Location and Contact Information
Indiana
Indiana University Affiliated Dialysis Unit, Indianapolis, Indiana, 46202, United States; Recruiting
Rajiv Agarwal, MD, Principal Investigator
More Information
Record last reviewed: February 2005
Last Updated: February 7, 2005
Record first received: August 25, 2003
ClinicalTrials.gov Identifier: NCT00067665
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- ACE (Lab Tests Online)

Not Signed In -

